Search clinical trials for: Squamous cell carcinoma of the head and neck (SCCHN)
Total 494190 results
-
Cascadian Therapeutics Inc.CompletedIncurable Metastatic Colorectal Carcinoma | Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckUnited States, Canada
-
AIO-Studien-gGmbHMerck Sharp & Dohme LLCNot yet recruitingSquamous Cell Carcinoma of the Larynx | Squamous Cell Carcinoma of the Oral Cavity | Squamous Cell Carcinoma of the Oropharynx | Squamous Cell Carcinoma of the HypopharynxGermany
-
Merck KGaA, Darmstadt, GermanyCompletedSquamous Cell Carcinoma of the Head and NeckJapan
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; AstraZeneca; Brigham and Women's Hospital; Loyola...CompletedSquamous Cell Carcinoma of Head and NeckUnited States
-
University Hospital, CaenUnknown
-
CelgeneCompletedCarcinoma, Squamous Cell of Head and NeckUnited States
-
Azienda Ospedaliero-Universitaria di ParmaFondazione IRCCS Istituto Nazionale dei Tumori, Milano; Heinrich-Heine University... and other collaboratorsUnknownCancer of Head and NeckGermany, Italy, Netherlands
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); AstraZeneca; MedImmune LLCCompletedHead and Neck Cancer | Mucositis | Xerostomia | Radiation Toxicity | Chemotherapeutic Agent ToxicityUnited States
-
Glycotope GmbHCompletedCetuGEX™ in Comparison to Cetuximab for the Treatment of Patients With Head and Neck Cancer (RESGEX)Carcinoma, Squamous Cell of Head and NeckBelgium, France, Germany, Italy, Poland, Romania, Spain
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.; Emory University; University of... and other collaboratorsTerminatedSquamous Cell Carcinoma of the Head and Neck (SCCHN)United States
-
IO BiotechMerck Sharp & Dohme LLC; Theradex; Almac; NeoGenomicsRecruitingHead and Neck Squamous Cell Carcinoma | Urothelial Carcinoma Bladder | Lung Cancer Non Small CellUnited States, Spain, United Kingdom
-
AIO-Studien-gGmbHBristol-Myers SquibbCompletedCarcinoma, Squamous Cell of Head and Neck | Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckGermany
-
AstraZenecaPRA Health SciencesCompletedRecurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and NeckUnited States, Belgium, Canada, France, Spain, Korea, Republic of, Hungary, Malaysia, United Kingdom, Taiwan, Germany, Georgia, Israel, Czechia
-
Immunovative Therapies, Ltd.WithdrawnSquamous Cell Carcinoma Head and NeckThailand
-
AstraZenecaPRA Health SciencesCompletedRecurrent/Metastatic Squamous Cell Carcinoma of Head & NeckUnited States, Canada, France, Spain, Belgium, Czechia, Korea, Republic of, Hungary, Malaysia, United Kingdom, Taiwan, Australia, Germany, Georgia, Israel
-
Peking UniversityBiotech Pharmaceutical Co., Ltd.Unknown
-
Assiut UniversityCompletedSquamous Cell Carcinoma of the Head and NeckEgypt
-
Merck KGaA, Darmstadt, GermanyMerck Ltd., IndiaTerminatedUnresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck | LA SCCHNIndia
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
Stanford UniversityNational Cancer Institute (NCI)CompletedSquamous Neck Carcinoma of the Head and Neck Cancer (SCCHN)United States
-
NanoCarrier Co., Ltd.Orient Europharma Co., Ltd.RecruitingSCCHNCroatia, Czechia, Hungary, Poland, Russian Federation, Serbia, Taiwan, Ukraine
-
Shanghai Miracogen Inc.Not yet recruitingSquamous Cell Carcinoma of the Head and NeckChina
-
GenmabCompletedHead and Neck Cancer | Squamous Cell CancerUnited States, Germany, Israel, Colombia, Czechia, Austria, Chile, Italy, Peru, Portugal, Slovakia
-
AHS Cancer Control AlbertaAlberta Cancer FoundationCompleted
-
Symphogen A/SCompletedCarcinoma, Squamous Cell of Head and NeckBelgium, France, Germany
-
Nanjing Tongren HospitalUnknownSquamous Cell Carcinoma of the Head and Neck | Circulating Tumor CellChina
-
Ezra CohenMerck Sharp & Dohme LLCActive, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States
-
University of MiamiTerminatedHead and Neck Cancer | Recurrent Disease | Squamous Cell CarcinomaUnited States
-
Neal ReadyAmgenTerminatedSquamous Cell Carcinoma of the Head and NeckUnited States
-
European Organisation for Research and Treatment...Active, not recruitingCarcinoma, Squamous Cell of Head and NeckFrance, Spain, Belgium, Italy, United Kingdom
-
Bristol-Myers SquibbCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Washington University School of MedicinePfizerCompletedCarcinoma, Squamous Cell of Head and NeckUnited States
-
Sensei Biotherapeutics, Inc.TerminatedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Geisinger ClinicGenentech, Inc.TerminatedHead and Neck CancerUnited States
-
HiberCell, Inc.CovanceTerminatedA Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)Clear Cell Renal Cell Carcinoma | Non Small Cell Lung Cancer | Squamous Cell Carcinoma of Head and Neck | Colo-rectal Cancer | Transitional Cell Carcinoma of the Bladder | Other Solid TumorsUnited States
-
Calliditas Therapeutics Suisse SAActive, not recruitingSquamous Cell Carcinoma of Head and NeckSpain, France, United States, Germany, Italy, Poland, United Kingdom
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Brigham and Women's HospitalCompletedC-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and NeckHead and Neck NeoplasmsUnited States
-
Hoffmann-La RocheTerminatedLocally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)United States, Korea, Republic of, Canada, Australia, Russian Federation, United Kingdom, Belgium, Brazil, China, France, Italy, Portugal, Spain, Japan, India, Thailand, Ukraine, Taiwan, Poland, Turkey, Hungary, South Africa, Germany
-
British Columbia Cancer AgencyWithdrawnLocally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)Canada
-
PfizerCompletedSquamous Cell Carcinoma of the Head and Neck (SCCHN)United States, Spain, Korea, Republic of, Czechia, Taiwan, Serbia, Japan, Slovakia, Mexico, Romania, Hungary, Italy, Poland, Russian Federation, Ukraine
-
Daiichi Sankyo, Inc.CompletedSquamous Cell Carcinoma of the Head and NeckUnited Kingdom
-
Eben RosenthalNational Cancer Institute (NCI)CompletedHead and Neck Cancer | Head and Neck Squamous Cell Carcinoma | Squamous Cell Carcinoma of the Head and Neck (SCCHN)United States
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKlineActive, not recruitingHead and Neck Cancer | Squamous Cell Carcinoma of the Head and NeckUnited States
-
GenmabCompletedHead and Neck CancerUnited Kingdom, Belgium, Slovakia, Hungary
-
Susanne ArnoldRecruitingHead and Neck Cancer | Carcinoma, Squamous CellUnited States
-
UNC Lineberger Comprehensive Cancer CenterCompletedHead and Neck Cancer | Squamous Cell Carcinoma of the Head and NeckUnited States
-
Dan ZandbergBristol-Myers SquibbActive, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States
-
Heath SkinnerCompletedSquamous Cell Carcinoma of the Head and Neck Cancer | Previously-IrradiatedUnited States
-
Biotech Pharmaceutical Co., Ltd.CompletedLocally Advanced Head and Neck Squamous Cell CarcinomaChina
-
Eye & ENT Hospital of Fudan UniversityNot yet recruitingHead and Neck Squamous Cell CarcinomaChina